MLKL is a potential prognostic marker in gastric cancer

  • Authors:
    • Wei Sun
    • Wenyan Yu
    • Lili Shen
    • Tieao Huang
  • View Affiliations

  • Published online on: July 29, 2019     https://doi.org/10.3892/ol.2019.10687
  • Pages: 3830-3836
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The mixed lineage kinase domain‑like protein (MLKL), which is a major mediator of the necroptosis pathway, is involved in a certain cancers. The present study aimed to explore the expression patterns and exact role of MLKL in gastric cancer (GC) tumorigenesis and progression. In Cancer Cell Line Encyclopedia analysis, the MLKL mRNA expression levels in GC cell lines were not higher compared with that in other cancer cell lines. The results of the present study demonstrated that MLKL expression was decreased in gastric cancer tissues compared with that in normal tissues. In the Kaplan‑Meier Plotter database survival analyses, decreased MLKL expression was associated with poor overall survival and first progression in patients with gastric cancer. In Oncomine gene co‑expression analysis, MLKL expression was significantly associated with fatty acid 2‑hydroxylase (FA2H) expression, which also exhibited similar effects on the prognosis of patients with GC in the survival analysis. This result suggested that FA2H may be a downstream molecule of MLKL. The results of the present study indicated that MLKL may be a novel prognostic biomarker for patients with GC.

Related Articles

Journal Cover

October 2019
Volume 18 Issue 4

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Sun, W., Yu, W., Shen, L., & Huang, T. (2019). MLKL is a potential prognostic marker in gastric cancer. Oncology Letters, 18, 3830-3836. https://doi.org/10.3892/ol.2019.10687
MLA
Sun, W., Yu, W., Shen, L., Huang, T."MLKL is a potential prognostic marker in gastric cancer". Oncology Letters 18.4 (2019): 3830-3836.
Chicago
Sun, W., Yu, W., Shen, L., Huang, T."MLKL is a potential prognostic marker in gastric cancer". Oncology Letters 18, no. 4 (2019): 3830-3836. https://doi.org/10.3892/ol.2019.10687